Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Viking Therapeutics, Inc. - Common Stock (NQ:VKTX)

35.06 +1.11 (+3.26%)
Streaming Delayed Price Updated: 10:14 AM EST, Dec 19, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Viking Therapeutics, Inc. - Common Stock

< Previous 1 2
...
14 15 16 17 18 19 20 21 22
...
28 29 Next >
News headline image
Eli Lilly Gains on the GLP-1 Weight Loss Phenomenon
Eli Lilly stock continues to move higher after the company reported continuing momentum for its flagship GLP-1 weight loss drugs 
Via MarketBeat
News headline image
Eli Lilly Raised Its Outlook. Is the Stock a Buy Now? ↗
The anti-obesity medication stock is way up, and there could be more fuel in the tank. 
Via The Motley Fool
News headline image
What Is the Best Weight Loss Stock to Buy Now? Our Top 3 Picks ↗
Data indicates that many more Americans have become aware of the dangers of obesity. Here are the best weight loss stocks to buy now. 
Via InvestorPlace
News headline image
Here's How Much You Would Have Made Owning Viking Therapeutics Stock In The Last 5 Years ↗
 
Via Benzinga
News headline image
Stock Market Crash Alert: 3 Must-Buy Biotech Stocks When Prices Plunge ↗
A slip in the market could give investors a rare opportunity to get some top biotech stocks to buy at a considerable discount. 
Via InvestorPlace
News headline image
Check Out What Whales Are Doing With VKTX ↗
 
Via Benzinga
News headline image
Can This High-Flying Stock 10x in 10 Years? ↗
This midcap biotech could see huge success ahead -- or disappointment. 
Via The Motley Fool
News headline image
Viking Therapeutics Unusual Options Activity ↗
 
Via Benzinga
News headline image
Looking At Viking Therapeutics's Recent Unusual Options Activity ↗
 
Via Benzinga
News headline image
10 Health Care Stocks With Whale Alerts In Today's Session ↗
 
Via Benzinga
News headline image
Is Viking Therapeutics Incredibly Undervalued? ↗
The biotech's weight loss drug candidate could fuel a premium-laden buyout, but risks abound. 
Via The Motley Fool
News headline image
1 Little-Known Vanguard Index Fund to Buy Before It Soars 50%, According to a Wall Street Analyst ↗
Tom Lee of Fundstrat Global Advisors thinks the small-cap Russell 2000 could climb 50% by the end of 2024. 
Via The Motley Fool
News headline image
3 Biotech Stocks to Buy on the Dip: April 2024 ↗
With medical innovation being a resilient space, investors can have confidence with these biotech stocks to buy on the dip. 
Via InvestorPlace
News headline image
3 Millionaire-Maker Biotech Stocks ↗
The risk at these companies is above average, and they're sure to remain volatile. This volatility, however, includes explosively bullish potential. 
Via The Motley Fool
News headline image
Market Whales and Their Recent Bets on VKTX Options ↗
 
Via Benzinga
News headline image
$100 Invested In Viking Therapeutics 5 Years Ago Would Be Worth This Much Today ↗
 
Via Benzinga
News headline image
VKTX Stock Earnings: Viking Therapeutics Beats EPS for Q1 2024 ↗
VKTX stock results show that Viking Therapeutics beat analyst estimates for earnings per share the first quarter of 2024. 
Via InvestorPlace
News headline image
Viking Therapeutics Reports Q1 Results: 'An Exceptional Period' Says CEO ↗
Viking Therapeutics reports quarterly losses of 26 cents per share which beat the analyst consensus estimate of losses of 28 cents by 7.14%. Research and development expenses were $24.1 million for the... 
Via Benzinga
News headline image
3 Biotech Stocks With Skyrocketing Potential: April 2024 ↗
These three biotech stocks, with robust fundamentals and long-term prospects represent the sector’s finest at this time. 
Via InvestorPlace
News headline image
3 Red-Hot Biotech Rockets Blasting Off in 2024 ↗
The economy is looking very strong and the biotech industry even more so, thus consider these top three stocks for strong profits. 
Via InvestorPlace
Topics Economy
News headline image
Missed Out on Novo Nordisk? 2 Healthcare Stocks With Big Catalysts on the Horizon. ↗
Good news could be just around the corner for two drugmakers not named Novo Nordisk. 
Via The Motley Fool
News headline image
Better Buy: Pfizer vs. Viking Therapeutics ↗
These two pharma stocks have followed distinct paths of late. Which is the better investment? 
Via The Motley Fool
News headline image
1 No-Brainer Vanguard Fund to Buy Right Now ↗
This Vanguard growth fund is home to some of the world's most innovative companies. 
Via The Motley Fool
News headline image
3 Stocks With the Potential to Surpass Analyst Expectations for 2024 ↗
These stocks to buy are set to surpass analyst expectations, with exciting product and service developments sparking unforeseen growth. 
Via InvestorPlace
News headline image
Wegovy vs. Zepbound: Who Wins the Battle of the GLP-1 Drugs?
The GLP-1 weight loss trend continues to flourish, and the ante keeps rising; see how the winner between Wegovy and Zepbound can help your portfolio 
Via MarketBeat
News headline image
These 3 Biotech Stocks Are Up 269% in 2024. Is There More to Come? ↗
These three biotech stocks are leading the sector higher on upbeat news but is this as good as it gets or do they have more gas in the tank? 
Via InvestorPlace
News headline image
Viking Therapeutics: Strong Results In Obesity ↗
With a potential best in class drug for oral and injectable use, Viking Therapeutics has to be on many Big Pharma/Bio acquisition wish lists, as the company represents a very scarce asset in the $100... 
Via Talk Markets
News headline image
3 Magnificent Stocks That Could Double or More by 2030 ↗
There's no guarantee these stocks will double by 2030, but their growth prospects look great. 
Via The Motley Fool
News headline image
Shed the Fat, Gain the Profits: 3 Weight-Loss Stocks to Own Until 2027 ↗
For investors looking for a way to play weight-loss stocks in this current backdrop, here are three top options to consider right now. 
Via InvestorPlace
News headline image
If You Can Only Buy One Biotech Stock in April, It Better Be One of These 3 Names ↗
Capitalize on the biotech sector's boom with these three top biotech stocks to buy, driven by aging demographics and advanced treatments. 
Via InvestorPlace
< Previous 1 2
...
14 15 16 17 18 19 20 21 22
...
28 29 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.